Antibody for specifically treating milk goat lamb aphtha and application thereof

CN120965865AActive Publication Date: 2025-11-18INNER MONGOLIA SHENGJIAN BIOTECHNOLOGY CO LTD
5 Cites 0 Cited by

Patent Information

Application Number
CN202511467910.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-10-15
Publication Date
2025-11-18
Estimated Expiration
2045-10-15

Smart Images

  • Figure CN120965865A_ABST
    Figure CN120965865A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of antibodies, and particularly relates to an antibody for specifically treating milk goat lamb aphtha and application of the antibody. The method comprises the following steps: collecting a virus solution at a diseased part of a diseased sheep, and carrying out subculture amplification on goat skin fibroblasts to obtain an ORFV virus strain; immunizing milk goats with the attenuated vaccine to prepare high-titer immune serum; the method comprises the following steps: separating ORFV specific B cells from PBMC (peripheral blood mononuclear cells) by adopting a flow sorting technology; antibody genes are amplified through nested PCR, an expression vector is constructed, and 293T cells are transfected to express the monoclonal antibody. The obtained monoclonal antibody 2 has high affinity and specificity, the sequence of a heavy chain CDR1-3 region of the monoclonal antibody 2 is SEQ ID NO: 1-3, and the sequence of a light chain CDR1-3 region of the monoclonal antibody 2 is SEQ ID NO: 4-6. The antibody can be used for diagnosing, treating and preventing the orf, has the characteristics of high efficiency, specificity and stability, and provides a new biological preparation for preventing and controlling the orf.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Anti-Orf virus B2L protein monoclonal antibody and application thereof

    CN103602636A

  • ORFV epidemic strain OV / HLJ / 04 monoclonal antibody 2E4 and application thereof

    CN106188247A

  • Anti-orf virus B2L protein antibody blocking ELISA detection kit and application thereof

    CN118064375A

  • Variants of CD38 antibody and uses thereof

    US20200017600A1

  • Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses

    WO2011111966A2